Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) requires mitochondrial oxidative phosphorylation (OXPHOS) to fuel its growth; however, broadly inhibiting this pathway might also disrupt essential mitochondrial functions in normal tissues. PDAC cells exhibit abnormally fragmented mitochondria that are essent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Yu, Meifang, Nguyen, Nicholas D., Huang, Yanqing, Lin, Daniel, Fujimoto, Tara N., Molkentine, Jessica M., Deorukhkar, Amit, Kang, Ya’an, San Lucas, F. Anthony, Fernandes, Conrad J., Koay, Eugene J., Gupta, Sonal, Ying, Haoqiang, Koong, Albert C., Herman, Joseph M., Fleming, Jason B., Maitra, Anirban, Taniguchi, Cullen M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6777817/
https://ncbi.nlm.nih.gov/pubmed/31335325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.126915
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados